Insiders · Profile

Poradosu Enrique

Chief Science & Business Off at Nuvectis Pharma. Filing since 4 Feb 2022. CIK 0001898147

Company
Date
Role
Action
Shares
Amount
Of holding
19 Nov 2024
Chief Science & Business Off
Bought
2,000
$9.98K
0.1%
10 May 2024
Chief Science & Business Off
Bought
500
$3.15K
0.0%
27 Mar 2023
Chief Science & Business Off
Bought
500
$5.78K
0.0%
12 May 2022
Chief Science & Business Off
Bought
670
$10.27K
0.1%
7 Feb 2022
Chief Science & Business Off
Bought
800
$3.10K
0.1%
4 Feb 2022
Chief Science & Business Off
Bought
3,800
$12.73K
0.3%
6 decisions on file.